Election `97: Drugs cash curbs may cause deaths
THE CONSULTANT'S TALE
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Dr Stephen Nussey, consultant endocrinologist at St George's hospital in Tooting, south London, says the refusal of health authorities and GP fundholders to pay for expensive drugs is causing unnecessary suffering and may have contributed to patient deaths.
"I had a 45-year-old patient who suffered from increasing confusion, poor memory and involuntary movements of his left arm and leg," he said.
"A brain scan showed a very large tumour in his pituitary gland. He had major surgery, but 21 days after the operation he was still drowsy, bed- bound and refusing to co-operate with the nurses.
"He was started on growth hormone and within a week he was transformed, walking round the ward and taking an active interest in his surroundings. He was discharged after two months.
"His GP, a fundholder, wrote to the health authority asking it to pay for the hormone, which costs up to pounds 10,000 a year.
"The GP said he was unwilling to spend 1/200th of his entire drug budget on one patient without additional help.
"The health authority refused and the growth hormone was stopped. The patient deteriorated markedly, especially mentally, and died at home five months after his operation.
"I cannot say the patient died because the hormone was withdrawn. But some patients are not getting hormone treatment despite clear benefits and the GP's letter makes it clear the decision is entirely financial.
"Health authorities are in effect saying `Yes, you can be treated for a pituitary tumour but if you survive it doesn't matter what your quality of life is like'."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments